Highlight

  • New Arrivals
  • Sale
  • Hot items
New

DIAZOLE 30’S

Login to view prices

GEND236

Description

DIAZOLE 30’S is an oral antidiabetic medication used in the management of type 2 diabetes mellitus. It typically contains Pioglitazone, a member of the thiazolidinedione (TZD) class, which works by enhancing the body’s sensitivity to insulin. This helps improve glycemic control in patients who do not achieve adequate results through diet, exercise, or other oral antidiabetic agents alone.

Mechanism of Action:
Pioglitazone, the likely active ingredient in DIAZOLE, acts primarily by activating peroxisome proliferator-activated receptors (PPAR-γ) in fat cells, muscle, and liver tissues. This results in improved cellular response to insulin without directly increasing insulin secretion, thus minimizing the risk of hypoglycemia when used alone.

Therapeutic Benefits:

  • Helps lower fasting and postprandial blood glucose levels

  • Reduces insulin resistance

  • Can be used as monotherapy or in combination with metformin, sulfonylureas, or insulin

  • May improve lipid profiles in some patients with diabetes

Usage:
The pack of 30 tablets provides a one-month course for most standard dosing regimens. Tablets should be taken once daily, with or without food, as prescribed by a healthcare provider. Regular monitoring of blood glucose, liver function, and overall metabolic health is essential during treatment.

Precautions:

  • Not suitable for type 1 diabetes or diabetic ketoacidosis

  • Use with caution in patients with heart failure or liver dysfunction

  • May cause weight gain, fluid retention, or edema in some individuals

Side Effects May Include:

  • Headache

  • Muscle aches

  • Mild gastrointestinal upset

  • Fluid retention or swelling

Always consult your healthcare provider before starting DIAZOLE, especially if you have existing medical conditions or are taking other medications.

Reviews

There are no reviews yet.

Be the first to review “DIAZOLE 30’S”

Your email address will not be published. Required fields are marked *

Select Your Location: